Department of Minimally Invasive Surgery Unit, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Department of Gynaecology and Minimally Invasive Unit, Vita Batel Hospital, Curitiba, Brazil.
J Obstet Gynaecol. 2021 Feb;41(2):176-186. doi: 10.1080/01443615.2019.1702934. Epub 2020 Feb 13.
The present review aims to analyse the current data available on the feasibility, safety and effectiveness of the minimally invasive surgical (MIS) treatment of diaphragmatic endometriosis (DE). Through the use of PubMed and Google Scholar database, we conducted a literature review of all available research related to diagnosis and treatment of DE, focussed on the minimally invasive techniques. The studies were selected independently by two authors according to the aim of this review. DE is an under-diagnosed disease affecting between 0.1% and 1.5% of fertile women. It is predominantly multiple, asymptomatic and highly associated with pelvic disease in about 50-90%. MIS techniques seems to be safe, effective and feasible in tertiary advanced endometriosis centre, offering definitive advantages in terms of hospital stay, post-operative pain and return to normal activity by using several surgical techniques as hydro-dissection plus resection, laser CO vaporisation, electrical fulguration, Sugarbaker peritonectomy, partial (shaving) and full-thickness diaphragmatic resection. Symptoms control range from 85% to 100%, with less than 3% of conversion, peri-operative complications and recurrence rate. All cases must be performed by multidisciplinary teams including at least a gynaecologist, thoracic surgeon and anaesthetist. The lack of prospective evaluation of DE interferes with the understanding about the natural history of disease and treatment results. Therefore, the development of adequate evidence-based recommendations about diagnosis, management and follow-up is difficult at this moment.
本综述旨在分析目前关于微创外科(MIS)治疗膈子宫内膜异位症(DE)的可行性、安全性和有效性的现有数据。通过使用 PubMed 和 Google Scholar 数据库,我们对所有与 DE 的诊断和治疗相关的研究进行了文献回顾,重点关注微创技术。这些研究是由两位作者根据本综述的目的独立选择的。DE 是一种发病率在 0.1%至 1.5%之间的未被充分诊断的疾病,主要为多发性、无症状性,并且与大约 50-90%的盆腔疾病高度相关。在三级先进的子宫内膜异位症中心,MIS 技术似乎是安全、有效和可行的,通过使用多种手术技术(如水力分离加切除术、激光 CO 蒸汽化、电灼、Sugarbaker 腹膜切除术、部分(刮除)和全层膈切除术),在住院时间、术后疼痛和恢复正常活动方面具有明显优势。症状控制范围从 85%到 100%不等,转化率、围手术期并发症和复发率均低于 3%。所有病例均应由包括妇科医生、胸外科医生和麻醉师在内的多学科团队进行操作。DE 的前瞻性评估缺乏,这妨碍了对疾病自然史和治疗结果的理解。因此,目前很难制定出关于 DE 的诊断、管理和随访的循证建议。